• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Leishmaniasis/Kala Azar
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Leishmaniasis/Kala Azar
    • View Item
    Jan 16, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Kimutai R et al - 2016 - Safety ...
    Size:
    579.4Kb
    Format:
    PDF
    Download
    Authors
    Kimutai, R
    Musa, AM
    Njoroge, S
    Omollo, R
    Alves, F
    Hailu, A
    Khalil, EAG
    Diro, E
    Soipei, P
    Musa, B
    Salman, K
    Ritmeijer, K
    Chappuis, F
    Rashid, J
    Mohammed, R
    Jameneh, A
    Makonnen, E
    Olobo, J
    Okello, L
    Sagaki, P
    Strub, N
    Ellis, S
    Alvar, J
    Balasegaram, M
    Alirol, E
    Wasunna, M
    Show allShow less
    Issue Date
    2017-01-09
    Submitted date
    2017-01-18
    
    Metadata
    Show full item record
    Journal
    Clinical Drug Investigation
    Abstract
    In 2010, WHO recommended a new first-line treatment for visceral leishmaniasis (VL) in Eastern Africa. The new treatment, a combination of intravenous (IV) or intramuscular (IM) sodium stibogluconate (SSG) and IM paromomycin (PM) was an improvement over SSG monotherapy, the previous first-line VL treatment in the region. To monitor the new treatment's safety and effectiveness in routine clinical practice a pharmacovigilance (PV) programme was developed.
    Publisher
    Springer Link
    URI
    http://hdl.handle.net/10144/618786
    DOI
    10.1007/s40261-016-0481-0
    PubMed ID
    28066878
    Language
    en
    ISSN
    1179-1918
    ae974a485f413a2113503eed53cd6c53
    10.1007/s40261-016-0481-0
    Scopus Count
    Collections
    Leishmaniasis/Kala Azar

    entitlement

    Related articles

    • Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
    • Authors: Musa A, Khalil E, Hailu A, Olobo J, Balasegaram M, Omollo R, Edwards T, Rashid J, Mbui J, Musa B, Abuzaid AA, Ahmed O, Fadlalla A, El-Hassan A, Mueller M, Mucee G, Njoroge S, Manduku V, Mutuma G, Apadet L, Lodenyo H, Mutea D, Kirigi G, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tafes H, Mekonnen Y, Makonnen E, Ndegwa S, Sagaki P, Kimutai R, Kesusu J, Owiti R, Ellis S, Wasunna M
    • Issue date: 2012
    • Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
    • Authors: Atia AM, Mumina A, Tayler-Smith K, Boulle P, Alcoba G, Elhag MS, Alnour M, Shah S, Chappuis F, van Griensven J, Zachariah R
    • Issue date: 2015 Dec
    • Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy.
    • Authors: Melaku Y, Collin SM, Keus K, Gatluak F, Ritmeijer K, Davidson RN
    • Issue date: 2007 Jul
    • Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
    • Authors: Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tesfaye S, Makonnen E, Khalil E, Ahmed O, Fadlalla A, El-Hassan A, Raheem M, Mueller M, Koummuki Y, Rashid J, Mbui J, Mucee G, Njoroge S, Manduku V, Musibi A, Mutuma G, Kirui F, Lodenyo H, Mutea D, Kirigi G, Edwards T, Smith P, Muthami L, Royce C, Ellis S, Alobo M, Omollo R, Kesusu J, Owiti R, Kinuthia J, Leishmaniasis East Africa Platform (LEAP) group.
    • Issue date: 2010 Oct 26
    • Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    • Authors: Hossain MS, Kumar A, Hossain AFMA, Mahshin M, Sharma A, Hossain MA, Sharma V, Haque R, Shamsuzzaman AKM, Maruf S, Ghosh P, Ahuja V, Mondal D
    • Issue date: 2018 Aug 13
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.